Pradaxa 150 mg capsule

Pradaxa is a well-known anticoagulant medication, specifically a direct thrombin inhibitor used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. The product visible in the image is the 150 mg capsule variant, featuring packaging in Bulgarian, indicating its distribution within the Eastern European market.

The brand was developed and is manufactured by Boehringer Ingelheim, a major German pharmaceutical company. Founded in 1885 by Albert Boehringer, the company remains one of the world's largest pharmaceutical firms and is notably still family-owned, which is unique among global industry leaders. The primary manufacturing facilities for Pradaxa are located in Germany, where the company maintains its global headquarters and core research hubs.